INSIGHTS ON DRUG DEVELOPMENT
-
![CPC]( "Optimizing Fluid Transfer Processes For Today And Beyond: Three Important Developments In Aseptic Connection Technology")
Optimizing Fluid Transfer Processes For Today And Beyond: Three Important Developments In Aseptic Connection TechnologyLearn about the latest aseptic connectors to help optimize today’s processes, and get a sneak peek into the future of single-use technology.
-
![Scientist laboratory pipette GettyImages-1140779660]( "ACQUITY And XBridge Premier Protein SEC 250 Å Columns: A New Benchmark In Inert SEC Column Design")
ACQUITY And XBridge Premier Protein SEC 250 Å Columns: A New Benchmark In Inert SEC Column DesignWe demonstrate the performance of a new column technology designed to provide a holistic solution to the problems of undesired secondary interactions in SEC.
-
![Quality control of liquid medicines-GettyImages-1132755385]( "Innovation Standardized – Bioseparation Methods For Biotherapeutics")
Innovation Standardized – Bioseparation Methods For BiotherapeuticsDiscover the most impactful standards in liquid chromatography (LC) for biotherapeutics. The standardizations include methods, columns, standards, and robustness.
-
![Bioprocess Bioreactor GettyImages-532549138]( "Performance Stability Of CORTECS 2.7 μm Columns Following Repeated Injections Of Precipitated Plasma")
Performance Stability Of CORTECS 2.7 μm Columns Following Repeated Injections Of Precipitated PlasmaWe review a column made using optimally packed solid-core particles. These columns are designed to tolerate repeated injections of minimally processed samples, while maintaining assay performance.
-
Improvements In Recovery, Reproducibility, And Matrix Effects With A Novel Solid Phase Extraction Sorbent6/30/2022
In this study we review a successful next generation reversed solid-phase extraction (SPE) product that produces cleaner extracts with simpler protocols and faster processing time.
-
Selecting A Reversed-Phase Column For The Peptide Mapping Analysis Of A Biotherapeutic Protein6/30/2022
In this study we review reversed-phase (RP) column selection considerations for peptide mapping applied to the routine characterization and analysis of biotherapeutic proteins.
-
BEH C18 Batch-To-Batch Robustness For The Analysis Of Rosuvastatin And Impurities6/30/2022
The main goal of this study is to investigate the long-term batch-to-batch reproducibility of 10 different lots of XBridge BEH C18 Columns. Discover the findings of this study.
-
A Look At Column Reproducibility: Analysis Of Endogenous Steroid Hormones In Serum6/30/2022
Having reproducible columns is critical for the success of batch to batch testing of stationary phases, as well as ensuring lifelong performance for the assay.
DRUG DEVELOPMENT SOLUTIONS
-
Backed by Lonza’s more than 30 years’ experience and expertise in biological processing and our track record in the chemical and biotechnological industry, we offer our customers a full “one-stop-shop” service package at all stages of development and production.
-
![API Image]( "Small Molecule API: Take A Big Picture Approach To Small Molecules")
Ensure that you always have the exact resources and expertise you need, especially for your most difficult to manufacture compounds.
-
Choose the right process development and manufacturing partner to guide your company through the many parameters along the drug development process.
-
We simplify pre-production workflows—for both upstream and downstream—by delivering fit-for-purpose process liquid and buffer preparation solutions that enable you to produce life-changing therapeutics and vaccines, faster.
-
![lonza]( "Container Closure Integrity Testing")
Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.
